Patents by Inventor Nicholas Eleuteri

Nicholas Eleuteri has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SELECTIVE HDAC6 DEGRADERS AND METHODS OF USE THEREOF
    Publication number: 20230011665
    Abstract: The present invention relates to bispecific compounds, compositions, and methods for treating diseases or conditions mediated by aberrant histone deacety lase 6 (HDAC6) activity.
    Type: Application
    Filed: November 5, 2020
    Publication date: January 12, 2023
    Applicant: DANA-FARBER CANCER INSTITUTE, INC.
    Inventors: Eric S. Fischer, Yuan Xiong, Katherine Donovan, Nicholas Eleuteri
  • SELECTIVE HISTONE DEACETYLASE (HDAC) DEGRADERS AND METHODS OF USE THEREOF
    Publication number: 20220401564
    Abstract: The present invention relates to bifunctional compounds, compositions, and methods for treating diseases or conditions mediated by aberrant histone deacetylase (HCADC) (e.g., HDAC3) activity.
    Type: Application
    Filed: November 5, 2020
    Publication date: December 22, 2022
    Applicant: DANA-FARBER CANCER INSTITUTE, INC.
    Inventors: Eric S. Fischer, Yuan Xiong, Katherine Donovan, Nicholas Eleuteri
  • SELECTIVE DUAL HISTONE DEACETYLASE 6/8 (HDAC6/8) DEGRADERS AND METHODS OF USE THEREOF
    Publication number: 20220387604
    Abstract: The present invention relates to bifunctional compounds, compositions, and methods for treating diseases or conditions mediated by aberrant histone deacetylases 6 and 8 (HDAC6/8) activity.
    Type: Application
    Filed: November 5, 2020
    Publication date: December 8, 2022
    Applicant: DANA-FARBER CANCER INSTITUTE, INC.
    Inventors: Eric S. Fischer, Yuan Xiong, Katherine Donovan, Nicholas Eleuteri